Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1997296 · MDCX, MDCXW

Medicus Pharma Ltd.

Filing with the SEC — delisting notice SEC-reporting company W. Conshohocken, PA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Oct 23, 2026 the company disclosed a notice from its exchange (Item 3.01): Nasdaq · minimum bid price. Exchanges usually give a period to regain compliance before delisting.
  • Stockholders’ deficitAt the end of 2025 stockholders’ equity was negative: −$68K (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $47.3M for the year (2024: −$11.2M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$47.3M−$11.2M
Total assets$10.1M$5.6M
Total liabilities$10M$2.5M
Stockholders’ equity−$68K$3.1M
Cash and equivalents$8.7M$4.2M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Medicus Pharma Ltd.
CIK
0001997296
Tickers
MDCX, MDCXW
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC — delisting notice
State of incorporation
Ontario, Canada
Business address
W. Conshohocken, Pennsylvania
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 23, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 6, 2026 · filing
  • Delisting determination: Nasdaq · minimum bid price
    Form 8-K · items 3.01, 8.01, 9.01 · filed Oct 23, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Sep 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 12, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.01, 2.03, 3.01, 9.01 · filed May 27, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.01, 3.01, 9.01 · filed Apr 24, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 25, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Dec 1, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Nov 19, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 29, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 29, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 2.01, 3.02, 5.02, 8.01, 9.01 · filed Sep 2, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 2.01, 3.02, 5.02, 8.01, 9.01 · filed Sep 2, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 11, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Jun 23, 2025 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Jun 5, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed May 30, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed May 27, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed May 27, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 28, 2025 · filing
  • Regulation A offering: Regulation A offering statement
    Form 1-A · filed Feb 14, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Nov 15, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 18, 2024 · filing
  • IPO registration filed: Registration statement (F-1)
    Form F-1 · filed May 29, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Oct 13, 2023 · filing